Procanbid

   
Google
 
Web NewDrugInformation.com

Procanbid


Drug - Procanbid
The trade name of the product as shown on the labeling.

Dosage - TABLET, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Procainamide Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 500MG
The potency of the active ingredient(s), Procainamide Hydrochloride. May repeat for multiple part products.

Applicant - KING PHARMS
The firm name holding legal responsibility for Procanbid. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020545
The FDA assigned number to Procanbid. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Procanbid. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jan 31, 1996
The date Procanbid was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Procanbid. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Procanbid is in. Format is RX, OTC, DISCN.

Applicant Full Name - King Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Procanbid.

Procanbid